Stacey Jennifer Evans

Executive VP & General Counsel at AUXILIUM PHARMACEUTICALS INC

Sold, on record
$745k
Dollars the filings state
Form 4 sales
4
Latest Sep 14, 2009
Form 144 notices
0
Proposed sales
Quarters with a sale
0 of the last 8
No sale in two years
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
4
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per year, every sale on record.

Sales chart range

Timeline

  1. Sep 14, 2009Unusual

    AUXILIUM PHARMACEUTICALS INC

    Sold 40.3% of their holdings

    $224k6,333 shares at $35.43

    Filed Sep 16, 2009Form 4

  2. Jul 24, 2009Unusual

    AUXILIUM PHARMACEUTICALS INC

    Sold 40.3% of their holdings

    $203k6,333 shares at $32.13

    Filed Jul 28, 2009Form 4

  3. Jan 6, 2009Unusual

    AUXILIUM PHARMACEUTICALS INC

    Sold 47.8% of their holdings

    $179k5,970 shares at $30.04

    Filed Jan 8, 2009Form 4

  4. Dec 18, 2008Unusual

    AUXILIUM PHARMACEUTICALS INC

    Sold 43.4% of their holdings

    $138k5,000 shares at $27.59

    Filed Dec 22, 2008Form 4

4 of 4

Every transaction

Every transaction on a Form 4 or Form 5 by Stacey Jennifer Evans
TradedFiledStockRoleWhatAmountPriceValueHeld afterSource
Aug 14, 2026Aug 14, 2026NEOGChief Legal OfficerAwardedCommon Stock (Right to Buy)196,276196,276SEC
Aug 14, 2026Aug 14, 2026NEOGChief Legal OfficerAwarded38,627$11.65$450k38,627SEC
Jun 24, 2026Jun 26, 2026CNTXDirectorAwardedStock Option (right to buy)45,00045,000SEC
May 1, 2026May 4, 2026NEOGChief Legal OfficerAwardedCommon Stock (Right to Buy)89,52089,520SEC
May 1, 2026May 4, 2026NEOGChief Legal OfficerAwarded39,349$9.53$375k39,349SEC
Jun 12, 2025Jun 12, 2025CNTXDirectorAwardedStock Option (right to buy)123,500123,500SEC
Jun 13, 2024Jun 14, 2024CNTXDirectorAwardedStock Option (right to buy)25,00025,000SEC
May 31, 2023May 31, 2023CNTXDirectorAwardedStock Option (right to buy)25,00025,000SEC
Feb 25, 2023Feb 28, 2023Galera Therapeutics, Inc.OfficerAwardedStock Option (Right to Buy)135,000135,000SEC
Jun 2, 2022Jun 3, 2022CNTXDirectorAwardedStock Option (right to buy)25,00025,000SEC
Feb 28, 2022Mar 2, 2022Galera Therapeutics, Inc.OfficerAwardedStock Option (Right to Buy)75,00075,000SEC
Oct 8, 2021Oct 12, 2021Galera Therapeutics, Inc.OfficerAwardedStock Option (Right to Buy)130,000130,000SEC
May 28, 2015Jun 1, 2015ANTARES PHARMA, INC.SVP, General Counsel & SectyWithheld for tax2,469$2.18$5k21,803SEC
May 28, 2015Jun 1, 2015ANTARES PHARMA, INC.SVP, General Counsel & SectyAwardedStock option (right to buy)142,550142,550SEC
May 28, 2015Jun 1, 2015ANTARES PHARMA, INC.SVP, General Counsel & SectyAwarded70,23992,042SEC
Mar 10, 2015Mar 12, 2015ANTARES PHARMA, INC.SVP, General Counsel & SectyAwardedStock option (right to buy)47,00047,000SEC
May 29, 2014Jun 2, 2014ANTARES PHARMA, INC.SVP, General Counsel & SectyAwardedStock option (right to buy)100,000100,000SEC
May 29, 2014Jun 2, 2014ANTARES PHARMA, INC.SVP, General Counsel & SectyAwarded72,81672,816SEC
Feb 28, 2011Apr 4, 2011AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselWithheld for tax941$22.47$21k16,878SEC
Feb 17, 2011Feb 22, 2011AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselAwardedNonqualified Stock Option (Right to Buy)40,00040,000SEC
Mar 12, 2010Mar 16, 2010AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselWithheld for tax941$30.20$28k17,819SEC
Feb 28, 2010Mar 2, 2010AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselAwardedNonqualified Stock Option (Right to Buy)35,00035,000SEC
Feb 28, 2010Mar 2, 2010AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselAwarded9,37818,760SEC
Sep 14, 2009Sep 16, 2009AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselSold6,333$35.43$224k9,382SEC
Sep 14, 2009Sep 16, 2009AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselExercised or settledNonqualified Stock Option (Right to Buy)6,33337,363SEC
Sep 14, 2009Sep 16, 2009AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselExercised options6,333$7.49$47k15,715SEC
Jul 24, 2009Jul 28, 2009AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselSold6,333$32.13$203k9,382SEC
Jul 24, 2009Jul 28, 2009AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselExercised or settledNonqualified Stock Option (Right to Buy)6,33338,363SEC
Jul 24, 2009Jul 28, 2009AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselExercised options6,333$7.49$47k15,715SEC
Feb 27, 2009Mar 3, 2009AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselAwardedNonqualified Stock Option (Right to Buy)20,00020,000SEC
Feb 25, 2009Feb 27, 2009AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselAwardedNonqualified Stock Option (Right to Buy)30,90030,900SEC
Jan 16, 2009Jan 21, 2009AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselWithheld for tax1,128$30.00$34k9,137SEC
Jan 16, 2009Jan 21, 2009AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselAwarded3,75010,265SEC
Jan 6, 2009Jan 8, 2009AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselSold5,970$30.04$179k6,515SEC
Jan 6, 2009Jan 8, 2009AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselExercised or settledNonqualified Stock Option (Right to Buy)5,97039,363SEC
Jan 6, 2009Jan 8, 2009AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselExercised options5,970$7.14$43k12,485SEC
Dec 18, 2008Dec 22, 2008AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselSold5,000$27.59$138k6,515SEC
Dec 18, 2008Dec 22, 2008AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselExercised or settledNonqualified Stock Option (Right to Buy)5,000105,000SEC
Dec 18, 2008Dec 22, 2008AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselExercised options5,000$5.36$27k11,515SEC
Feb 22, 2008Feb 26, 2008AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselAwardedNonqualified Stock Options (Right to Buy)20,00020,000SEC
Sep 19, 2007Nov 2, 2007AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselAwardedNonqualified Stock Option (Right to Buy)10,00010,000SEC
Feb 23, 2007Feb 27, 2007AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselAwardedNonqualified Stocks Option (Right to Buy)40,00040,000SEC
Jun 6, 2006Jun 8, 2006AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselAwardedNonqualified Stock Option (Right to Buy)45,00045,000SEC

Sales and notices (4)

Form 144 notices and Form 4 sales by Stacey Jennifer Evans
Source
Sep 14, 2009Sep 16, 2009AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselForm 4 sale6,333$224k40.3%UnusualSEC
Jul 24, 2009Jul 28, 2009AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselForm 4 sale6,333$203k40.3%UnusualSEC
Jan 6, 2009Jan 8, 2009AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselForm 4 sale5,970$179k47.8%UnusualSEC
Dec 18, 2008Dec 22, 2008AUXILIUM PHARMACEUTICALS INCExecutive VP & General CounselForm 4 sale5,000$138k43.4%UnusualSEC